Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -383.15% is 54% below its 5-year average of -248.05%, around the middle of its 5-year range (-811.26%–25.30%).
26.16% below its 12-month average of -303.71%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -49.47%.
OPERATING MARGIN
-383.15%
OPERATING MARGIN AVG TTM
-303.71%
OPERATING MARGIN AVG 3Y
-345.28%
OPERATING MARGIN AVG 5Y
-248.05%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-26.16%
CURRENT VS 3Y AVG
-10.97%
CURRENT VS 5Y AVG
-54.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
OmniAb, Inc.
Market Cap
$616.28M
Operating Margin
-383.15%
TTM Avg
-303.71%
3Y Avg
-345.28%
5Y Avg
-248.05%
Market Cap
$620.48M
Operating Margin
-85.01%
TTM Avg
-96.97%
3Y Avg
-124.64%
5Y Avg
-134.49%
Market Cap
$626.92M
Operating Margin
-3.98%
TTM Avg
-186.23%
3Y Avg
-243.00%
5Y Avg
-164.54%
Market Cap
$632.51M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$601.66M
Operating Margin
40.10%
TTM Avg
33.30%
3Y Avg
-21.49%
5Y Avg
1.14%
Market Cap
$595.19M
Operating Margin
-12.47%
TTM Avg
-13.07%
3Y Avg
-26.14%
5Y Avg
-20.95%
Market Cap
$647.51M
Operating Margin
-4498.06%
TTM Avg
-5642.71%
3Y Avg
-2821.36%
5Y Avg
-1883.89%
Market Cap
$657.39M
Operating Margin
-4.44%
TTM Avg
-7.18%
3Y Avg
-7.18%
5Y Avg
-7.18%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $616.28M | -383.15% | -303.71% | -345.28% | -248.05% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $620.48M | -85.01% | -96.97% | -124.64% | -134.49% |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $626.92M | -3.98% | -186.23% | -243.00% | -164.54% |
| Climb Bio, Inc. (CLYM)vs › | $612.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aura Biosciences, Inc. (AURA)vs › | $632.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.66M | 40.10% | 33.30% | -21.49% | 1.14% |
| AngioDynamics, Inc. (ANGO)vs › | $595.19M | -12.47% | -13.07% | -26.14% | -20.95% |
| Prime Medicine, Inc. (PRME)vs › | $647.51M | -4498.06% | -5642.71% | -2821.36% | -1883.89% |
| Starling Oncology, Inc. (STLN)vs › | $657.39M | -4.44% | -7.18% | -7.18% | -7.18% |
| MiMedx Group, Inc. (MDXG)vs › | $658.11M | 15.26% | 16.07% | 9.54% | 2.83% |
Gross Margin
-18.2%
Operating Margin
-383.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -49.47% |
| 2026-03-31 | -54.86% |
| 2025-12-31 | -186.75% |
| 2025-09-30 | -811.26% |
| 2025-06-30 | -416.19% |
| 2025-03-31 | -453.64% |
| 2024-12-31 | -146.98% |
| 2024-09-30 | -473.73% |
| 2024-06-30 | -214.14% |
| 2024-03-31 | -593.34% |
| 2023-12-31 | -439.78% |
| 2023-09-30 | -370.62% |
| 2023-06-30 | -277.93% |
| 2023-03-31 | -49.67% |
| 2022-12-31 | 25.30% |
| 2022-09-30 | -218.77% |
| 2022-06-30 | -172.26% |
| 2022-03-31 | -90.06% |
| 2021-12-31 | -21.71% |
| 2021-09-30 | -2.72% |
| 2021-06-30 | -190.58% |
| 2021-03-31 | -157.15% |
| 2020-12-31 | -17.98% |
| 2020-09-30 | -166.49% |
